These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12605847)

  • 21. Acquired combined immunodeficiency associated with protein losing enteropathy complicating Fontan operation.
    Chakrabarti S; Keeton BR; Salmon AP; Vettukattil JJ
    Heart; 2003 Oct; 89(10):1130-1. PubMed ID: 12975395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Perioperative Management of Fontan Operation].
    Sughimoto K; Miyaji K
    Kyobu Geka; 2017 Jul; 70(8):627-633. PubMed ID: 28790279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-losing enteropathy secondary to Fontan procedure resolved after cardiac transplantation.
    Sierra C; Calleja F; Picazo B; Martinez-Valverde A
    J Pediatr Gastroenterol Nutr; 1997 Feb; 24(2):229-30. PubMed ID: 9106114
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful use of long-acting octreotide for protracted gastrointestinal bleeding related to protein-losing enteropathy after the Fontan procedure: a case report.
    Kogawa K; Ando T; Fujiwara M
    Cardiol Young; 2021 Aug; 31(8):1333-1335. PubMed ID: 33588957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverse multi-organ histopathologic changes in a failed Fontan patient.
    Mizuno M; Ohuchi H; Matsuyama TA; Miyazaki A; Ishibashi-Ueda H; Yamada O
    Pediatr Int; 2016 Oct; 58(10):1061-1065. PubMed ID: 27616284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
    Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
    Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-losing enteropathy after Fontan operation.
    Rychik J
    Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult-Onset Fontan Circuit Failure: A Rare Cause of Protein-Losing Enteropathy.
    Tai CH; Baranowski E; Zhang X; Li DK
    Clin Gastroenterol Hepatol; 2024 Jan; 22(1):A24-A25. PubMed ID: 37516376
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
    John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
    Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein-losing enteropathy in patients with fontan operations.
    Stiller B
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):528-30. PubMed ID: 14581789
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein-losing enteropathy after the Fontan operation: successful treatment by percutaneous fenestration of the atrial septum.
    Warnes CA; Feldt RH; Hagler DJ
    Mayo Clin Proc; 1996 Apr; 71(4):378-9. PubMed ID: 8637261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. For the management of protein-losing enteropathy, Gut-heart-relation in patients with Fontan circulation.
    Yumita Y; Niwa K
    Int J Cardiol; 2024 Apr; 400():131783. PubMed ID: 38244894
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation.
    Ono S; Ohuchi H; Miyazaki A; Yamada O
    Pediatr Cardiol; 2018 Oct; 39(7):1290-1298. PubMed ID: 29789917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal haemorrhage in protein-losing enteropathy associated with the Fontan circulation.
    Seewoodhary J
    QJM; 2010 May; 103(5):347-9. PubMed ID: 19917646
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of caval venous manipulation in treatment of protein-losing enteropathy.
    Menon S; Hagler D; Cetta F; Gloviczki P; Driscoll D
    Cardiol Young; 2008 Jun; 18(3):275-81. PubMed ID: 18325142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The problem of follow-up period after Fontan operation].
    Putiato NA; Shvedunova VN; Astrakhantseva TO; Samsonov VB; Podzolkov VP
    Vestn Ross Akad Med Nauk; 2009; (1):33-7. PubMed ID: 19253688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome.
    Silvilairat S; Cabalka AK; Cetta F; Grogan M; Hagler DJ; O'Leary PW
    Congenit Heart Dis; 2008; 3(4):262-8. PubMed ID: 18715460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-losing enteropathy resolved by percutaneous intervention.
    Butera G; Marini D; MacDonald ST
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):584-8. PubMed ID: 21805565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation.
    Kim SJ; Park IS; Song JY; Lee JY; Shim WS
    Ann Thorac Surg; 2004 Apr; 77(4):1456-7. PubMed ID: 15063295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure.
    Powell AJ; Gauvreau K; Jenkins KJ; Blume ED; Mayer JE; Lock JE
    Am J Cardiol; 2001 Nov; 88(10):1206-9. PubMed ID: 11703976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.